Insulin Degludec, known and marketed under the trade names Tresiba, Xultophy (combination with Liraglutide), and Ryzodec (combination with insulin Aspart), is an ultra-long-acting insulin used in the treatment of type 1 and type 2 diabetes. While Insulin Detemir is a long-acting insulin, insulin isophane is intermediate-acting, and insulin Lispro is a rapid-acting.
The correct answer is C.
References:
Comments
Post a Comment